Clinical trials
Active, not recruiting Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
204 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 10 |
| 2018 | 9 |
| 2019 | 13 |
| 2020 | 11 |
| 2021 | 24 |
| 2022 | 25 |
| 2023 | 27 |
| 2024 | 32 |
| 2025 | 29 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 204 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 5 |
| Vanderbilt University Medical Center | 5 |
| University of Pennsylvania | 4 |
| Centre for Addiction and Mental Health | 3 |
| Dartmouth-Hitchcock Medical Center | 3 |
| Eli Lilly and Company | 3 |
| Instituto Mexicano del Seguro Social | 3 |
| University of Alabama at Birmingham | 3 |
| University of California, Los Angeles | 3 |
| University of California, San Diego | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 204 |
| Alzheimer Disease | 53 |
| Dementia | 40 |
| Memory Disorders | 11 |
| Stroke | 10 |
| Neurocognitive Disorders | 8 |
| Inflammation | 7 |
| Parkinson Disease | 7 |
| Mental Disorders | 6 |
| Anxiety Disorders | 5 |
Trials
Showing 51 to 75 of 204. Each trial links to its page on Pharma Observatory.
104 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.